Asia Pacific Clinical Trials Supplies Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product & Service (Manufacturing, Packaging & Labelling, and Logistics & Distribution), Stage (Phase I, Phase II, Phase III, and Bioequivalence Studies), Drug Type (Small-Molecule Drugs and Biologic Drugs), and Application (Oncology, Cardiovascular Diseases, Neurological Disorders, Respiratory Disorders, and Others)

Code: TIPRE00022076 | Pages: 152 | Industry: Pharmaceuticals | Date: May 2021 | Type: Regional

Market Introduction

The clinical trial is an investigation study that defines whether a medical approach, therapy, or device is effective, safe, and useful for human applications. These studies help to find which therapeutic approaches experiment is best for certain diseases. Clinical trial supplies management is necessary for evading overproduction, oversupply, and inventory expiration. With the increasing costs of drug discovery, clinical trial supplies are obtaining more importance.

 


Get more information on this report :



Market Overview and Dynamics

The Asia Pacific clinical trial supplies market is expected to reach US$ 735.66 Mn by 2027 from US$ 397.66 Mn in 2019; it is estimated to grow at a CAGR of 8.1% from 2020 to 2027. The growth of the market is attributed to some key driving factors such as increasing prevalence of chronic diseases, low cost of conducting a clinical trial compared to western region and increasing government initiatives to conduct clinical trials. However, challenges for clinical trials due to negative impact of COVID-19 pandemic is expected to restraint the growth of the market during the forecast years.

Clinical trial supplies management is necessary for evading overproduction, oversupply, and inventory expiration. With the increasing costs of drug discovery, clinical trial supplies are obtaining more importance. The growing healthcare sector in developing countries of Asia-Pacific creates better opportunities for the clinical trial supplies management market players to expand their business. The huge patient population in these countries is generating demand for more clinical trials. The increasing number of clinical trials conducted in Asia Pacific is ascribed to low operational costs, large patient recruitment potential, growth of contract research organizations (CROs), favorable regulatory environment, and better clinical trials capacity and quality. Increase in incidence of chronic diseases in Asia is a key factor that is likely to contributing to the surge in the number of clinical trials in Asia. Moreover, the clinical trials in Asia cost ~30–40% lower than the US and the EU, as the doctor visits, medical treatments, and procedures are less expensive in Asian countries. Also, higher cost of drug development process in developed countries will help propel market growth.

Since the surge of COVID-19 cases, the pharmaceutical industry is facing a decrease in production capabilities, resulting in drug shortages. Moreover, diversion of resources from drug development to coronavirus treatment is likely to hamper overall productivity of the drug development for a short period of span. Various pharmaceutical companies made decisions to postpone the ongoing clinical trials due to disrupted supply chains and threat of the virus. However, several contract research organizations based in Asia Pacific are engaged in a large number of clinical trials for different therapeutics. The outbreak has forced many CROs to close their manufacturing and development plants to avoid the increase in cases. Thus, the COVID-19 pandemic had a positive as well as negative impact on the Asia Pacific clinical trial supplies market.

 

Key Market Segments

In terms of product & service, the Asia Pacific clinical trial supplies market is segmented into manufacturing, packaging & labelling, and logistics & distribution. The logistics & distribution segment held the largest share of the market in 2019; the same segment is anticipated to register the highest CAGR in the market during the forecast period.

Based on stage, the Asia Pacific clinical trial supplies market is segmented into phase I, phase II, phase III, and bioequivalence studies. The phase III segment held the largest share of the market in 2019 and is estimated to register the highest CAGR in the market during the forecast period.

In terms of drug type, the Asia Pacific clinical trial supplies market is segmented into small-molecule drugs and biologic drugs. The small-molecule drugs segment held the largest share of the market in 2019, whereas the biologic drugs segment is estimated to register the highest CAGR in the market during the forecast period.

Based on application, the Asia Pacific clinical trial supplies market has been segmented into oncology, cardiovascular diseases, neurological disorders, respiratory disorders, and others. The oncology segment held the largest share of the market in 2019 and is estimated to register the highest CAGR during the forecast period.

 

Major Sources and Companies Listed

A few of the primary and secondary sources associated with this report on the Asia Pacific clinical trial supplies market are the India Brand Equity Foundation (IBEF), National Institute for Health (NIH) and Association of Clinical Research Organizations (ACRO).

 

Reasons to buy the report

  • Determine prospective investment areas based on a detailed trend analysis of Asia Pacific clinical trial supplies market over the next years.
  • Gain an in-depth understanding of the underlying factors driving demand for different addictions therapeutics segments in the top spending countries and identify the opportunities offered by each of them.
  • Strengthen your knowledge of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
  • Identify the major channels driving the Asia Pacific clinical trial supplies market, providing a clear picture of future opportunities that will help Analyze, resulting in revenue expansion.
  • Channelize resources by focusing on the ongoing programs undertaken by the different countries within the Asia Pacific clinical trial supplies market.

 

ASIA PACIFIC CLINICAL TRIAL SUPPLIES MARKET SEGMENTATION

By Product & Service

  • Manufacturing
  • Packaging & Labelling
  • Logistics & Distribution

By Stage

  • Phase I
  • Phase II
  • Phase III
  • Bioequivalence Studies

By Drug Type

  • Small-molecule Drugs
  • Biologic Drugs

By Application

  • Oncology
  • Cardiovascular Diseases
  • Neurological Disorders
  • Respiratory Disorders
  • Others

By Country

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific

Company Profiles

  • THERMO FISHER SCIENTIFIC INC.
  • UDG Healthcare plc
  • Catalent Inc.
  • pci Pharma Services
  • Almac Group
  • PAREXEL INTERNATIONAL CORPORATION
  • Biocair
  • Owens & Minor Inc
  • Rubicon Research Pvt. Ltd
 

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Asia Pacific Clinical Trial Supplies Market – By Product & Service

1.3.2        Asia Pacific Clinical Trial Supplies Market – By Stage

1.3.3        Asia Pacific Clinical Trial Supplies Market – By Drug Type

1.3.4        Asia Pacific Clinical Trial Supplies Market – By Application

1.3.5        Asia Pacific Clinical Trial Supplies Market – By Country

2.           Clinical Trial Supplies Market – Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Asia Pacific Clinical Trial Supplies Market– Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        Asia Pacific – PEST Analysis

4.3         Expert Opinion

5.           Clinical Trial Supplies – Key Market Dynamics

5.1         Market Drivers

5.1.1        Increasing Pharmaceutical and Biopharmaceutical R&D Expenditures

5.1.2        Higher Cost of Drug Development Process in Developed Countries

5.2         Market Restraints

5.2.1        Rising Cost of Drug Development and Clinical Trials

5.2.2        Challenges for Clinical Trials Due to Negative Impact of Corona Virus

5.3         Key Market Opportunities

5.3.1        Growing Opportunities in Developing Nations

5.4         Future Trends

5.4.1        Growing Biosimilars and Biologics Market

5.5         Impact analysis

6.           Clinical Trial Supplies Market – Asia Pacific Analysis

6.1         Asia Pacific Clinical Trial Supplies Market Revenue Forecast and Analysis

7.           Clinical Trial Supplies Market Analysis – By Product & Service

7.1         Overview

7.2         Clinical Trial Supplies Market Revenue Share, by Product and Service (2019 and 2027)

7.3         Logistics & Distribution

7.3.1        Overview

7.3.2        Logistics & Distribution: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

7.4         Manufacturing

7.4.1        Overview

7.4.2        Manufacturing: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

7.5         Packaging & Labelling

7.5.1        Overview

7.5.2        Packaging & Labelling: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

8.           Clinical Trial Supplies Market – By Stage

8.1         Overview

8.2         Clinical Trial Supplies Market, by Stage, 2019 and 2027 (%)

8.3         Phase III

8.3.1        Overview

8.3.2        Phase III: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

8.4         Phase II

8.4.1        Overview

8.4.2        Phase II: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

8.5         Bioequivalence Studies

8.5.1        Overview

8.5.2        Bioequivalence Studies: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

8.6         Phase I

8.6.1        Overview

8.6.2        Phase I: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

9.           Clinical Trial Supplies Market – By Drug Type

9.1         Overview

9.2         Clinical Trial Supplies Market, by Drug Type 2019 and 2027 (%)

9.3         Small-molecule Drugs

9.3.1        Overview

9.3.2        Small-molecule Drugs: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

9.4         Biologic Drugs

9.4.1        Overview

9.4.2        Biologic Drugs: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

10.        Clinical Trial Supplies Market – By Application

10.1      Overview

10.2      Clinical Trial Supplies Market, by Application 2019 and 2027 (%)

10.3      Oncology

10.3.1     Overview

10.3.2     Oncology: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

10.4      Cardiovascular Diseases

10.4.1     Overview

10.4.2     Cardiovascular Diseases: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

10.5      Neurological Disorders

10.5.1     Overview

10.5.2     Neurological Disorders: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

10.6      Respiratory Disorders

10.6.1     Overview

10.6.2     Respiratory Disorders: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

10.7      Others

10.7.1     Overview

10.7.2     Others: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

11.        Clinical Trial Supplies Market – Asia Pacific Analysis

11.1      Asia Pacific: Clinical Trial Supplies Market

11.1.1     Overview

11.1.2     Asia Pacific: Clinical Trial Supplies Market, by Country, 2018 & 2027 (%)

11.1.3     China: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)

11.1.3.1       China: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)

11.1.3.2       China: Clinical Trial Supplies Market, by Product & Service, 2018–2027 (USD Million)

11.1.3.3       China: Clinical Trial Supplies Market, by Stage, 2018–2027 (USD Million)

11.1.3.4       China: Clinical Trial Supplies Market, by Drug Type, 2018–2027 (USD Million)

11.1.3.5       China: Clinical Trial Supplies Market, by Application, 2018–2027 (USD Million)

11.1.4     Japan: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)

11.1.4.1       Japan: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)

11.1.4.2       Japan: Clinical Trial Supplies Market, by Product & Service, 2018–2027 (USD Million)

11.1.4.3       Japan: Clinical Trial Supplies Market, by Stage, 2018–2027 (USD Million)

11.1.4.4       Japan: Clinical Trial Supplies Market, by Drug Type, 2018–2027 (USD Million)

11.1.4.5       Japan: Clinical Trial Supplies Market, by Application, 2018–2027 (USD Million)

11.1.5     India: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)

11.1.6     India: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)

11.1.6.1       India: Clinical Trial Supplies Market, by Product & Service, 2018–2027 (USD Million)

11.1.6.2       India: Clinical Trial Supplies Market, by Stage, 2018–2027 (USD Million)

11.1.6.3       India: Clinical Trial Supplies Market, by Drug Type, 2018–2027 (USD Million)

11.1.6.4       India: Clinical Trial Supplies Market, by Application, 2018–2027 (USD Million)

11.1.7     South Korea: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)

11.1.7.1       South Korea: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)

11.1.7.2       South Korea: Clinical Trial Supplies Market, by Product & Service, 2018–2027 (USD Million)

11.1.7.3       South Korea: Clinical Trial Supplies Market, by Stage, 2018–2027 (USD Million)

11.1.7.4       South Korea: Clinical Trial Supplies Market, by Drug Type, 2018–2027 (USD Million)

11.1.7.5       South Korea: Clinical Trial Supplies Market, by Application, 2018–2027 (USD Million)

11.1.8     Australia: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)

11.1.8.1       Australia: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)

11.1.8.2       Australia: Clinical Trial Supplies Market, by Product & Service, 2018–2027 (USD Million)

11.1.8.3       Australia: Clinical Trial Supplies Market, by Stage, 2018–2027 (USD Million)

11.1.8.4       Australia: Clinical Trial Supplies Market, by Drug Type, 2018–2027 (USD Million)

11.1.8.5       Australia: Clinical Trial Supplies Market, by Application, 2018–2027 (USD Million)

12.        Impact of COVID-19 Pandemic on Asia Pacific Clinical Trial Supplies Market

12.1      Asia-Pacific: Impact Assessment of COVID-19 Pandemic

13.        Clinical Trials Supplies Market – Industry Landscape

13.1      Overview

13.2      Organic Developments

13.2.1     Overview

13.3      Inorganic Developments

13.3.1     Overview

14.        Clinical Trial Supplies Market – Key Company Profiles

14.1      THERMO FISHER SCIENTIFIC INC.

14.1.1     Key Facts

14.1.2     Business Description

14.1.3     Products and Services

14.1.4     Financial Overview

14.1.5     SWOT Analysis

14.1.6     Key Developments

14.2      UDG Healthcare plc

14.2.1     Key Facts

14.2.2     Business Description

14.2.3     Products and Services

14.2.4     Financial Overview

14.2.5     SWOT Analysis

14.2.6     Key Developments

14.3      Catalent Inc.

14.3.1     Key Facts

14.3.2     Business Description

14.3.3     Products and Services

14.3.4     Financial Overview

14.3.5     SWOT Analysis

14.3.6     Key Developments

14.4      pci Pharma Services

14.4.1     Key Facts

14.4.2     Business Description

14.4.3     Products and Services

14.4.4     Financial Overview

14.4.5     SWOT Analysis

14.4.6     Key Developments

14.5      Almac Group

14.5.1     Key Facts

14.5.2     Business Description

14.5.3     Products and Services

14.5.4     Financial Overview

14.5.5     SWOT Analysis

14.5.6     Key Developments

14.6      PAREXEL INTERNATIONAL CORPORATION

14.6.1     Key Facts

14.6.2     Business Description

14.6.3     Products and Services

14.6.4     Financial Overview

14.6.5     SWOT Analysis

14.6.6     Key Developments

14.7      Biocair

14.7.1     Key Facts

14.7.2     Business Description

14.7.3     Products and Services

14.7.4     Financial Overview

14.7.5     SWOT Analysis

14.7.6     Key Developments

14.8      Owens & Minor Inc.

14.8.1     Key Facts

14.8.2     Business Description

14.8.3     Products and Services

14.8.4     Financial Overview

14.8.5     SWOT Analysis

14.8.6     Key Developments

14.9      Rubicon Research Pvt. Ltd.

14.9.1     Key Facts

14.9.2     Business Description

14.9.3     Products and Services

14.9.4     Financial Overview

14.9.5     SWOT Analysis

14.9.6     Key Developments

15.        Appendix

15.1      About the Insight Partners

15.2      Glossary of Terms

LIST OF TABLES

Table 1.             China: Major Global Pharmaceutical Companies by R&D investments, 2013`

Table 2.             China Clinical Trial Supplies Market, by Product & Service – Revenue and Forecast to 2027 (USD Million)

Table 3.             China Clinical Trial Supplies Market, by Stage – Revenue and Forecast to 2027 (USD Million)

Table 4.             China Clinical Trial Supplies Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)

Table 5.             China Clinical Trial Supplies Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 6.             Japan Clinical Trial Supplies Market, by Product & Service – Revenue and Forecast to 2027 (USD Million)

Table 7.             Japan Clinical Trial Supplies Market, by Stage – Revenue and Forecast to 2027 (USD Million)

Table 8.             Japan Clinical Trial Supplies Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)

Table 9.             Japan Clinical Trial Supplies Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 10.          India: R&D spending of Pharmaceutical companies (2010 & 2017)

Table 11.          India Clinical Trial Supplies Market, by Product & Service – Revenue and Forecast to 2027 (USD Million)

Table 12.          India Clinical Trial Supplies Market, by Stage – Revenue and Forecast to 2027 (USD Million)

Table 13.          India Clinical Trial Supplies Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)

Table 14.          India Clinical Trial Supplies Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 15.          South Korea Clinical Trial Supplies Market, by Product & Service – Revenue and Forecast to 2027 (USD Million)

Table 16.          South Korea Clinical Trial Supplies Market, by Stage – Revenue and Forecast to 2027 (USD Million)

Table 17.          South Korea Clinical Trial Supplies Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)

Table 18.          South Korea Clinical Trial Supplies Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 19.          Australia Clinical Trial Supplies Market, by Product & Service – Revenue and Forecast to 2027 (USD Million)

Table 20.          Australia Clinical Trial Supplies Market, by Stage – Revenue and Forecast to 2027 (USD Million)

Table 21.          Australia Clinical Trial Supplies Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)

Table 22.          Australia Clinical Trial Supplies Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 23.          Organic Developments Done by Companies

Table 24.          Inorganic Developments Done by Companies

Table 25.          Glossary of Terms, Clinical Trial Supplies Market

LIST OF FIGURES

Figure 1.           Clinical Trial Supplies Market Segmentation

Figure 2.           Clinical Trial Supplies Segmentation, By Country

Figure 3.           Asia Pacific Clinical Trial Supplies Market Overview

Figure 4.           Logistics & Distribution Segment Held Largest Share of Product & Service Segment in Clinical Trial Supplies Market

Figure 5.           Phase III Segment Held Largest Share of Stage Segment in Clinical Trial Supplies Market

Figure 6.           Small-molecule Drugs Segment Held Largest Share of Drug type Segment in Clinical Trial Supplies Market

Figure 7.           Oncology Segment Held Largest Share of Application Segment in Clinical Trial Supplies Market

Figure 8.           China Is Expected to Show Remarkable Growth During the Forecast Period

Figure 9.           Asia pacific PEST Analysis

Figure 10.        Clinical Trial Supplies Market Impact Analysis of Drivers and Restraints

Figure 11.        Asia Pacific Clinical Trial Supplies Market – Revenue Forecast and Analysis – 2019- 2027

Figure 12.        Clinical Trial Supplies Market Revenue Share, by Product and Service (2019 and 2027)

Figure 13.        Logistics & Distribution: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

Figure 14.        Manufacturing: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

Figure 15.        Packaging & Labelling: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

Figure 16.        Clinical Trial Supplies Market, by Stage 2019 and 2027 (%)

Figure 17.        Phase III: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

Figure 18.        Phase II: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

Figure 19.        Bioequivalence Studies: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

Figure 20.        Phase I: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

Figure 21.        Clinical Trial Supplies Market, by Drug Type, 2019 and 2027 (%)

Figure 22.        Small-molecule Drugs: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

Figure 23.        Biologics Drugs: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

Figure 24.        Clinical Trial Supplies Market, by Application, 2019 and 2027 (%)

Figure 25.        Oncology: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

Figure 26.        Cardiovascular Diseases: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

Figure 27.        Neurological Disorders: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

Figure 28.        Respiratory Disorders: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

Figure 29.        Others: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

Figure 30.        Asia Pacific: Clinical Trial Supplies Market, by Key Country – Revenue (2019) (USD Million)

Figure 31.        China: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)

Figure 32.        Japan: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)

Figure 33.        India: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)

Figure 34.        South Korea: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)

Figure 35.        Australia: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)

Figure 36.        Impact of COVID-19 Pandemic in Asia Pacific Country Markets

 

  1. THERMO FISHER SCIENTIFIC INC.
  2. UDG Healthcare plc
  3. Catalent Inc.
  4. pci Pharma Services
  5. Almac Group
  6. PAREXEL INTERNATIONAL CORPORATION
  7. Biocair
  8. Owens & Minor Inc
  9. Rubicon Research Pvt. Ltd

 

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
Site License
$4000
Enterprise License
$5000